. 2018 Jan 25;8:1975. doi: 10.3389/fimmu.2017.01975

Table 1.

Patient characteristics.

Patient	Blast%	Surface markers	Ph⁺	Cytogenetics
UPN1	72	CD10⁺, CD19⁺, CD34⁺, CD20⁺	−	46 XX, −12
UPN2	95	CD10⁺, CD19⁺, CD34⁺, TdT	−	39–47, XX, −6, +5, +8, +11, −18, −19
UPN3	96	CD10⁻, CD19⁺, CD34⁺, CD20⁻	−	46 XX, t(4;11)
UPN4	91	CD10⁺, CD19⁺, CD34^dim, CD20^dim, TdT	−	47 XY, +21
UPN5	97	CD10⁺, CD19⁺, CD34⁺, CD20⁺	+	Diploid
UPN6	92	CD10^dim, CD19⁺, CD34⁺, CD20^partial	−	46 XY
UPN7	87	CD10⁺, CD19⁺, CD34⁺, CD20⁻	+	46 XX, t(9;22), +21
UPN8	92	CD10⁺, CD19⁺, CD34⁺, CD20^dim	−	45, 46 XY, −6, −9